Langabeer, S E <br/><br/>
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.  [electronic resource] 

 -  Leukemia  Mar 2002 
 - 393-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402392  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acridines<br/>Bone Marrow Transplantation<br/>DNA Probes<br/>Fusion Proteins, bcr-abl--genetics<br/>Gene Amplification<br/>Graft Enhancement, Immunologic<br/>Humans<br/>Hybridization, Genetic<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis<br/>Luminescent Measurements<br/>Neoplasm Recurrence, Local--diagnosis<br/>Polymerase Chain Reaction<br/>RNA, Messenger--analysis<br/>RNA, Neoplasm--analysis<br/>Risk Factors<br/>Succinimides<br/>Transcription, Genetic